• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良 Gleason 分级:最新综述

Modified Gleason grading. An updated review.

作者信息

Helpap Burkhard, Egevad Lars

机构信息

Department of Pathology, Center of Uropathology, General Hospital Hegau-Bodensee-Klinikum Singen, Academic Hospital of the University of Freiburg, Germany.

出版信息

Histol Histopathol. 2009 May;24(5):661-6. doi: 10.14670/HH-24.661.

DOI:10.14670/HH-24.661
PMID:19283673
Abstract

UNLABELLED

At an ISUP (International Society of Urological Pathology) consensus conference in 2005 in San Antonio, Texas, the old Gleason grading system for prostatic carcinoma from 1966 underwent its first major revision. With this modified Grading system a shift of the most frequent Gleason scores from 6 to 7a (3+4) in biopsy specimens and an increased degree of agreement between specimens of biopsies and radical prostatectomies with carcinoma of the prostate could be demonstrated. After modified grading of GS 3+4=7a tumours 95% were stage pT2, while 79% of GS 4+3=7b tumours were stage pT3-4. In cases with PSA <10 ng/ml and tumour extent <20% the most frequent Gleason scores were 6 and 7a. Cases with serum PSA >10 ng/ml or tumour extent >20% had higher scores (7b or higher). Cancers with tumour infiltration of <1mm in one of 12 cores and PSA <10 ng/ml were mainly low grade (Gleason scores 6 and 7a) and may correspond to so called insignificant carcinoma of the prostate.

CONCLUSION

With the modified Gleason system, grade, stage, tumour extent and serum PSA show good correlations and characterize the difference between low and high grade malignancy of prostate carcinoma.

摘要

未标注

在2005年于得克萨斯州圣安东尼奥举行的国际泌尿病理学会(ISUP)共识会议上,1966年的旧前列腺癌Gleason分级系统首次进行了重大修订。采用这种改良的分级系统,可以证明活检标本中最常见的Gleason评分从6分转变为7a(3 + 4)分,并且前列腺癌活检标本与根治性前列腺切除术标本之间的一致性程度有所提高。对GS 3 + 4 = 7a肿瘤进行改良分级后,95%为pT2期,而GS 4 + 3 = 7b肿瘤的79%为pT3 - 4期。在PSA < 10 ng/ml且肿瘤范围 < 20%的病例中,最常见的Gleason评分为6分和7a分。血清PSA > 10 ng/ml或肿瘤范围 > 20%的病例评分更高(7b或更高)。在12个核心标本中有1个肿瘤浸润 < 1mm且PSA < 10 ng/ml的癌症主要为低级别(Gleason评分6分和7a分),可能对应于所谓的前列腺微小癌。

结论

采用改良的Gleason系统,分级、分期、肿瘤范围和血清PSA显示出良好的相关性,并可区分前列腺癌低级别和高级别恶性肿瘤之间的差异。

相似文献

1
Modified Gleason grading. An updated review.改良 Gleason 分级:最新综述
Histol Histopathol. 2009 May;24(5):661-6. doi: 10.14670/HH-24.661.
2
[The value of the modified Gleason grading system of prostate adenocarcinoma in routine urological diagnostics].[改良版前列腺腺癌Gleason分级系统在常规泌尿外科诊断中的价值]
Urologe A. 2007 Jan;46(1):59-62. doi: 10.1007/s00120-006-1238-9.
3
Correlation of modified Gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens.前列腺癌改良Gleason分级与年龄、血清前列腺特异性抗原及穿刺活检标本中肿瘤范围的相关性
Anal Quant Cytol Histol. 2008 Jun;30(3):133-8.
4
The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.2005年国际泌尿病理学会共识会议对前列腺穿刺活检中前列腺癌Gleason分级标准的影响。
J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11.
5
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.当代前列腺癌的Gleason分级:结合对实施2014年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议实际问题的讨论进行更新
Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820.
6
[Clinical insignificance of prostate cancer: are there morphological findings?].[前列腺癌的临床无意义:是否存在形态学发现?]
Urologe A. 2009 Feb;48(2):170-4. doi: 10.1007/s00120-008-1867-2.
7
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.SOCS3免疫组化表达似乎支持2005年和2014年国际泌尿病理学会(ISUP)改良的Gleason分级系统。
Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.
8
The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.改良Gleason分级在前列腺癌活检及根治性前列腺切除标本中的意义。
Virchows Arch. 2006 Dec;449(6):622-7. doi: 10.1007/s00428-006-0310-6. Epub 2006 Nov 8.
9
Gleason inflation 1998-2011: a registry study of 97,168 men.格里森评分膨胀 1998-2011:97168 名男性的注册研究。
BJU Int. 2015 Feb;115(2):248-55. doi: 10.1111/bju.12671.
10
Gleason scoring: a comparison of classical and modified (international society of urological pathology) criteria using nadir PSA as a clinical end point.格里森评分:以 PSA 最低值为临床终点,比较经典和改良(国际泌尿病理学会)标准。
Pathology. 2010 Jun;42(4):339-43. doi: 10.3109/00313021003787924.

引用本文的文献

1
Comparing Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) Category 1 and 2 Groups: Clinical Implication of Negative Multiparametric Magnetic Resonance Imaging.比较前列腺影像报告和数据系统第 2 版(PI-RADSv2)类别 1 和 2 组:阴性多参数磁共振成像的临床意义。
Biomed Res Int. 2020 Mar 31;2020:2819701. doi: 10.1155/2020/2819701. eCollection 2020.
2
Appetite-regulating hormones-leptin, adiponectin and ghrelin-and the development of prostate cancer: a systematic review and exploratory meta-analysis.食欲调节激素——瘦素、脂联素和胃饥饿素——与前列腺癌的发生发展:系统评价和探索性荟萃分析。
Prostate Cancer Prostatic Dis. 2020 Mar;23(1):11-23. doi: 10.1038/s41391-019-0154-1. Epub 2019 May 30.
3
Grading of prostate cancer: a work in progress.
前列腺癌分级:一项正在进行中的工作。
Histopathology. 2019 Jan;74(1):146-160. doi: 10.1111/his.13767.
4
High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?正常上皮组织中高表达的 miR-205 与生化失败相关——这是否表明前列腺癌中存在上皮细胞间的串扰?
Sci Rep. 2017 Nov 24;7(1):16308. doi: 10.1038/s41598-017-16556-2.
5
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort.免疫检查点标志物程序性细胞死亡蛋白1(PD-1)和程序性死亡配体1(PD-L1)在一个大型多中心前列腺癌队列中的预后作用。
Oncotarget. 2017 Apr 18;8(16):26789-26801. doi: 10.18632/oncotarget.15817.
6
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.前列腺癌基质中 PDGFR-β 的高表达与临床和生化前列腺癌复发独立相关。
Sci Rep. 2017 Feb 24;7:43378. doi: 10.1038/srep43378.
7
Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome.雌激素受体 α 和 β 以及芳香酶作为前列腺癌结局的独立预测因子。
Sci Rep. 2016 Sep 9;6:33114. doi: 10.1038/srep33114.
8
The evolving Gleason grading system.不断发展的格里森分级系统。
Chin J Cancer Res. 2016 Feb;28(1):58-64. doi: 10.3978/j.issn.1000-9604.2016.02.04.
9
[Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].[前列腺癌。第2部分:1966 - 2015年期间各种肿瘤分级系统回顾以及国际泌尿病理学会(ISUP)新分级的未来展望]
Pathologe. 2016 Feb;37(1):11-6. doi: 10.1007/s00292-015-0124-x.
10
The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.准确测定Gleason评分对前列腺癌治疗方案及预后的意义
Pathol Oncol Res. 2016 Apr;22(2):349-56. doi: 10.1007/s12253-015-0013-x. Epub 2015 Nov 12.